Meritech's Handwashing Systems Removed 99.997% of E-Coli in Laboratory Studies
GOLDEN, Colo.--(BUSINESS WIRE)--Meritech, a division of Resurgent Health and Medical and a leader in automated handwashing and sanitizing technology, announced today that independent clinical laboratory studies showed that Meritech’s handwashing systems removed 99.997% of E-Coli, a marker organism used to test the efficacy of Meritech’s hand hygiene products. The studies were performed in June 2008 at BioScience Laboratories in Bozeman, MT.
“We are thrilled with the results of the many studies we have performed over the years and particularly pleased with our recent clinical results that demonstrate the effectiveness of our technology in cleaning and sanitizing hands”, said Jim Glenn, CEO of Resurgent Health and Medical and Meritech. “There is a growing awareness of the problem of poor hand hygiene practices in the health care and food industries and of the infections and illnesses caused world wide by the failure to observe basic hand washing guidelines. Our goal as a company is to provide a technology and a product line to help in the effort to eliminate these infections and illnesses, and we are very pleased with our recent round of clinical testing that demonstrates just how effective our products are. More and more companies and hospitals throughout the world are adopting our technology as part of their commitment to reduce these risks.”
This study evaluated the performance of Meritech’s Elf automated hand cleansing system set for a total cycle length of 12 seconds using 5 ml Chlorhexidine Gluconate 2% (CHG) antimicrobial agent against E-Coli as the marker organism. The transient microorganism reduction by Meritech’s automated system was measured at a statistical summary of the mean log10 of 3.49, which equated to a reduction of 99.97% removal of the E-Coli, with some results having a higher log10 of up to 4.54, which equates to a reduction of 99.997% removal of the organism. These studies involve rigorous testing by an independent laboratory using up to 16 human test subjects in an environment intended to duplicate conditions found in health care and food industry environments. Unlike in vitro studies, these clinical studies demonstrate the effectiveness of Meritech’s products in actual use.
The testing methods are based on the methodology specified by the Food and Drug Administration Tentative Final Monograph (TFM) for Effectiveness Testing of an Antiseptic Handwash or Health-Care Personnel Handwash (FR59:116, 17 June 94, pp. 31448-31450) and ASTM E 1174 Standard Test method for Evaluation of the Effectiveness of Healthcare Personnel Handwash Formulations.
The CleanTech touchless system performs a fully-automated twelve-second wash, sanitize and rinse cycle. Using Meritech’s proprietary Chlorhexidine Gluconate 2% (CHG2%) sanitizing solution, Meritech’s hand hygiene products remove over 99.9% of pathogens and continue to kill germs for up to six hours. The FDA certified CHG-based sanitizer contains mild skin conditioners to continuously improve skin health while removing dangerous germs.
The system further boosts compliance by ensuring a pleasant, uniform hand wash using high-pressure water jets that perform a consistent wash-and-sanitize cycle every time the machines are used.
About Meritech & Resurgent Health & Medical
Meritech and Resurgent Health and Medical delivers state of the art employee hygiene technologies to food industries, hospitals, and healthcare facilities that are serious about infection prevention and the elimination of dangerous pathogens in the industry. Our patented CleanTech® infection prevention technology brings science and precision to the process of removing dangerous microbes from employee hands. For almost 20 years, CleanTech® brand systems have been used worldwide in agriculture, food processing, food service, cleanroom manufacturing and healthcare. CleanTech uses up to 75% less water than manual handwashing, discharges 75% less wastewater, and reduces waste in soap utilization.
For more information, visit http://www.resurgenthealth.com or http://www.meritech.com
Press release taken from Business Wire
“We are thrilled with the results of the many studies we have performed over the years and particularly pleased with our recent clinical results that demonstrate the effectiveness of our technology in cleaning and sanitizing hands”, said Jim Glenn, CEO of Resurgent Health and Medical and Meritech. “There is a growing awareness of the problem of poor hand hygiene practices in the health care and food industries and of the infections and illnesses caused world wide by the failure to observe basic hand washing guidelines. Our goal as a company is to provide a technology and a product line to help in the effort to eliminate these infections and illnesses, and we are very pleased with our recent round of clinical testing that demonstrates just how effective our products are. More and more companies and hospitals throughout the world are adopting our technology as part of their commitment to reduce these risks.”
This study evaluated the performance of Meritech’s Elf automated hand cleansing system set for a total cycle length of 12 seconds using 5 ml Chlorhexidine Gluconate 2% (CHG) antimicrobial agent against E-Coli as the marker organism. The transient microorganism reduction by Meritech’s automated system was measured at a statistical summary of the mean log10 of 3.49, which equated to a reduction of 99.97% removal of the E-Coli, with some results having a higher log10 of up to 4.54, which equates to a reduction of 99.997% removal of the organism. These studies involve rigorous testing by an independent laboratory using up to 16 human test subjects in an environment intended to duplicate conditions found in health care and food industry environments. Unlike in vitro studies, these clinical studies demonstrate the effectiveness of Meritech’s products in actual use.
The testing methods are based on the methodology specified by the Food and Drug Administration Tentative Final Monograph (TFM) for Effectiveness Testing of an Antiseptic Handwash or Health-Care Personnel Handwash (FR59:116, 17 June 94, pp. 31448-31450) and ASTM E 1174 Standard Test method for Evaluation of the Effectiveness of Healthcare Personnel Handwash Formulations.
The CleanTech touchless system performs a fully-automated twelve-second wash, sanitize and rinse cycle. Using Meritech’s proprietary Chlorhexidine Gluconate 2% (CHG2%) sanitizing solution, Meritech’s hand hygiene products remove over 99.9% of pathogens and continue to kill germs for up to six hours. The FDA certified CHG-based sanitizer contains mild skin conditioners to continuously improve skin health while removing dangerous germs.
The system further boosts compliance by ensuring a pleasant, uniform hand wash using high-pressure water jets that perform a consistent wash-and-sanitize cycle every time the machines are used.
About Meritech & Resurgent Health & Medical
Meritech and Resurgent Health and Medical delivers state of the art employee hygiene technologies to food industries, hospitals, and healthcare facilities that are serious about infection prevention and the elimination of dangerous pathogens in the industry. Our patented CleanTech® infection prevention technology brings science and precision to the process of removing dangerous microbes from employee hands. For almost 20 years, CleanTech® brand systems have been used worldwide in agriculture, food processing, food service, cleanroom manufacturing and healthcare. CleanTech uses up to 75% less water than manual handwashing, discharges 75% less wastewater, and reduces waste in soap utilization.
For more information, visit http://www.resurgenthealth.com or http://www.meritech.com
Press release taken from Business Wire
posted by meritech at
11:07 AM
0 Comments:
Post a Comment
<< Home